Cargando…

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling

BACKGROUND: We were tasked by the South African Department of Health to assess the cost implications to the largest ART programme in the world of adopting sets of ART guidelines issued by the World Health Organization between 2010 and 2016. METHODS: Using data from large South African ART clinics (n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meyer-Rath, Gesine, Johnson, Leigh F., Pillay, Yogan, Blecher, Mark, Brennan, Alana T., Long, Lawrence, Moultrie, Harry, Sanne, Ian, Fox, Matthew P., Rosen, Sydney
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662079/ https://www.ncbi.nlm.nih.gov/pubmed/29084275 http://dx.doi.org/10.1371/journal.pone.0186557

Ejemplares similares

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

What will it take for an injectable ARV to change the face of the HIV epidemic in high‐prevalence countries? Considerations regarding drug costs and operations
por: Meyer‐Rath, Gesine, et al.
Publicado: (2023)

Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment
por: Rosen, Sydney, et al.
Publicado: (2010)

Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data
por: Benade, Mariet, et al.
Publicado: (2022)

Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
por: Jo, Youngji, et al.
Publicado: (2021)

Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
por: Long, Lawrence, et al.
Publicado: (2011)

World AIDS Day 2020: Reflections on global and South African progress and continuing challenges
por: Pillay, Yogan, et al.
Publicado: (2021)

The role of modelling and analytics in South African COVID-19 planning and budgeting
por: Meyer-Rath, Gesine, et al.
Publicado: (2023)

When donor funding leaves: an interrupted time-series analysis of the impact of integrating direct HIV care and treatment into public health services in a region of Johannesburg
por: Lince-Deroche, Naomi, et al.
Publicado: (2019)

HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Retention in Care and Outpatient Costs for Children Receiving Antiretroviral Therapy in Zambia: A Retrospective Cohort Analysis
por: Scott, Callie A., et al.
Publicado: (2013)

Effect of antiretroviral therapy on patients’ economic well being: five-year follow-up
por: Rosen, Sydney, et al.
Publicado: (2014)

Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study
por: Bor, Jacob, et al.
Publicado: (2017)

Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on antiretroviral treatment in public sector treatment programs in South Africa
por: Brennan, Alana T., et al.
Publicado: (2018)

Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa
por: Larson, Bruce A, et al.
Publicado: (2010)

Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
por: Benade, Mariet, et al.
Publicado: (2022)

Assessing the impact of the National Department of Health’s National Adherence Guidelines for Chronic Diseases in South Africa using routinely collected data: a cluster-randomised evaluation
por: Fox, Matthew P, et al.
Publicado: (2018)

The updated South African National Guideline for the Prevention of Mother to Child Transmission of Communicable Infections (2019)
por: Wessels, Jeannette, et al.
Publicado: (2020)

The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data
por: Rosen, Sydney, et al.
Publicado: (2011)

Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort
por: Takuva, Simbarashe, et al.
Publicado: (2014)

The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa
por: Brennan, Alana T, et al.
Publicado: (2010)

The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2019)

Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough
por: Larson, Bruce A., et al.
Publicado: (2013)

The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

Who is seeking antiretroviral treatment for HIV now? Characteristics of patients presenting in Kenya and South Africa in 2017‐2018
por: Brennan, Alana T, et al.
Publicado: (2019)

The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa
por: Masuku, Sithabiso D., et al.
Publicado: (2023)

Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness
por: Johnson, Leigh F., et al.
Publicado: (2019)

Mobilizing resources with an investment case to mitigate cross-border malaria transmission and achieve malaria elimination in South Africa
por: Kollipara, Aparna, et al.
Publicado: (2023)

Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
por: Takuva, Simbarashe, et al.
Publicado: (2013)

Patient Perspectives of Quality of the Same-Day Antiretroviral Therapy Initiation Process in Gauteng Province, South Africa: Qualitative Dominant Mixed-Methods Analysis of the SLATE II Trial
por: Scott, Nancy A., et al.
Publicado: (2020)

Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa
por: Fox, Matthew P., et al.
Publicado: (2014)

Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa
por: Moyo, Faith, et al.
Publicado: (2016)

Getting resources to those who need them: the evidence we need to budget for underserved populations in sub‐Saharan Africa
por: Long, Lawrence C, et al.
Publicado: (2021)

CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data
por: Kufa, Tendesayi, et al.
Publicado: (2019)

Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia
por: Iyer, Hari S., et al.
Publicado: (2014)

Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care
por: Maskew, Mhairi, et al.
Publicado: (2018)

Rationing Antiretroviral Therapy for HIV/AIDS in Africa: Choices and Consequences
por: Rosen, Sydney, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ankfnht9532a4i373ans6sq3n8